Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
Primary Purpose
Gastric Residual Volume, Preterm Infant, Feeding Disorder Neonatal
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
No Gastric residual volume monitoring
Sponsored by
About this trial
This is an interventional supportive care trial for Gastric Residual Volume focused on measuring gastric residuals, feeding, very low birth weight infants
Eligibility Criteria
Inclusion Criteria:
- Birth weight ≤1250g
- Gestational age of < 33 weeks
- Expected to receive feeds via gastric tubes
Exclusion Criteria:
- Death expected within 72 hours of birth
- Major chromosomal or congenital anomaly
- Major GI anomaly such as gastroschisis, spontaneous perforation etc.
Sites / Locations
- AdventHealth
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
GRV group
NO GRV group
Arm Description
Gastric residuals will be checked prior to feeds
Gastric residuals will not be checked prior to feeds
Outcomes
Primary Outcome Measures
Days to reach full enteral feeds
Days to reach enteral feeding volume of 120ml/kg/day
Secondary Outcome Measures
Necrotizing enterocolitis
Stage 2 NEC and higher grade
weight gain
Weight gain velocity in gm/kg/d
frequency of feeding interruptions
Number of timed feeds are withheld
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04062851
Brief Title
Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
Official Title
Routine Versus no Assessment of Gastric Residual Volumes in Very Low Birth Weight Infants Receiving Enteral Feeding Via Intermittent Feeding Tubes: A Randomized Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
May 3, 2019 (Actual)
Primary Completion Date
July 26, 2021 (Actual)
Study Completion Date
March 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AdventHealth
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize that not monitoring GRV in infants with birth weights < 1,250 g, and who are being fed intermittently by gastric tube, will result in earlier attainment of full feeding. This is an unblinded randomized controlled trial where GRV will not be checked routinely in the intervention group.
Detailed Description
The term "gastric residuals" in neonates refers to aspiration of gastric contents before each feeding in an infant receiving enteral feeding using an intermittent feeding tube. The presence of significant gastric residual volume (GRV) (Greater than 50% of the feeding volume) is a manifestation of delayed gastrointestinal maturation in a preterm neonate. The presence of GRV and its characteristics usually delays advancement of enteral feedings in premature infants because a large volume of undigested milk usually prompts the clinicians to hold the feeding.
Advancement of early enteral nutrition is delayed or discontinued for >24 hours in nearly 75% of all extremely preterm infants. This is despite clinical evidence showing that early establishment of enteral nutrition is associated with reductions in the severity of critical illness, and long-lasting benefits on linear growth and neurodevelopmental outcomes.
The magnitude and characteristics of GRV combined with specific findings based on abdominal examinations are usually considered by clinicians in decisions to continue with the scheduled enteral feeding plan. There are no studies to establish the normal volume of gastric residuals, its characteristics and whether routinely checking for them prior to each feed prevents necrotizing enterocolitis. A recent cohort study using retrospective controls showed that not monitoring GRV is associated with earlier attainment of full feeding in very low birth weight infants. Two small randomized studies conducted outside the United States and one study conducted in the United States showed no difference in outcomes when GRV are not checked routinely in preterm infants. These studies have several drawbacks and the practice of checking GRV continues.
Study Objectives
Primary Objective/Aim/Goal/Hypothesis
The primary objective of this study is to demonstrate that not monitoring GRV in infants with birth weights < 1,250 g, and who are being fed intermittently by gastric tube, will result in earlier attainment of full feeding.
Hypothesis:
In preterm infants, changing the clinical practice from routine gastric residuals evaluation to no aspiration for gastric residuals will decrease the number of days to reach full enteral feeds.
Secondary Objective/Aim/Goal/Hypothesis
A secondary objective is to show that there will be no difference in the incidence of NEC (necrotizing enterocolitis) in the experimental vs the control group.
Sample Size Determination
Our NICU database shows that for infants <1,250 g the days to full feeding was 16.4 ±7.3 days. To detect a relative decrease of 20% in the experimental group will require 73 infants in each group with an alpha of 0.05 and a power of 0.8.
Statistical Analysis Plan
Primary Objective Analysis
The primary outcome analysis is the number of days to reach full feeding volume, defined as volume > 120 ml/kg/d. This time will be compared between the two groups using analysis of variance.
Secondary Objective Analysis
Secondary analysis will be focused the frequency of feeding interruptions, incidences of NEC between the two groups using analysis of variance.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastric Residual Volume, Preterm Infant, Feeding Disorder Neonatal
Keywords
gastric residuals, feeding, very low birth weight infants
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Unblinded Single center Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
GRV group
Arm Type
No Intervention
Arm Description
Gastric residuals will be checked prior to feeds
Arm Title
NO GRV group
Arm Type
Experimental
Arm Description
Gastric residuals will not be checked prior to feeds
Intervention Type
Other
Intervention Name(s)
No Gastric residual volume monitoring
Intervention Description
Gastric residual volumes will not be monitored
Primary Outcome Measure Information:
Title
Days to reach full enteral feeds
Description
Days to reach enteral feeding volume of 120ml/kg/day
Time Frame
1 month after enrollment
Secondary Outcome Measure Information:
Title
Necrotizing enterocolitis
Description
Stage 2 NEC and higher grade
Time Frame
Until hospital discharge, an average of 2-6 months
Title
weight gain
Description
Weight gain velocity in gm/kg/d
Time Frame
4 weeks chronological age and 36 weeks corrected gestation
Title
frequency of feeding interruptions
Description
Number of timed feeds are withheld
Time Frame
Until full feeds are reached, usually between 2 weeks - 2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Hours
Maximum Age & Unit of Time
1 Month
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Birth weight ≤1250g
Gestational age of < 33 weeks
Expected to receive feeds via gastric tubes
Exclusion Criteria:
Death expected within 72 hours of birth
Major chromosomal or congenital anomaly
Major GI anomaly such as gastroschisis, spontaneous perforation etc.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Narendra Dereddy, MD
Organizational Affiliation
AdventHealth
Official's Role
Principal Investigator
Facility Information:
Facility Name
AdventHealth
City
Orlando
State/Province
Florida
ZIP/Postal Code
32803
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
25129325
Citation
Li YF, Lin HC, Torrazza RM, Parker L, Talaga E, Neu J. Gastric residual evaluation in preterm neonates: a useful monitoring technique or a hindrance? Pediatr Neonatol. 2014 Oct;55(5):335-40. doi: 10.1016/j.pedneo.2014.02.008. Epub 2014 Aug 14.
Results Reference
result
PubMed Identifier
25166623
Citation
Torrazza RM, Parker LA, Li Y, Talaga E, Shuster J, Neu J. The value of routine evaluation of gastric residuals in very low birth weight infants. J Perinatol. 2015 Jan;35(1):57-60. doi: 10.1038/jp.2014.147. Epub 2014 Aug 28.
Results Reference
result
PubMed Identifier
25633400
Citation
Parker L, Torrazza RM, Li Y, Talaga E, Shuster J, Neu J. Aspiration and evaluation of gastric residuals in the neonatal intensive care unit: state of the science. J Perinat Neonatal Nurs. 2015 Jan-Mar;29(1):51-9; quiz E2. doi: 10.1097/JPN.0000000000000080.
Results Reference
result
Learn more about this trial
Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
We'll reach out to this number within 24 hrs